R263K-associated dolutegravir resistance on tenofovir, lamivudine and dolutegravir: Implications for earlier genotyping and regimen optimisation. [PDF]
S Afr J Infect DisNaidoo S.
europepmc +1 more source
HIV/AIDS: Research and Palliative CareNuredin Chura Waritu,1 Suresh Kumar P Nair,2 Bihonegn Birhan2 ,† Tesfaye Adugna,2 Gesese Bogale Awgichew,2 Mohammed Jemal3 1Department of Biomedical Sciences, School of Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia; 2Department of Biomedical ...
Waritu NC +5 more
doaj
Antiretroviral therapy and associated drug interactions with cardiovascular drugs: a critical review. [PDF]
Front PharmacolSpanakis M, Alexakis K, Ioannou P.
europepmc +1 more source
Caution with PBPK Modeling Based on the In Vitro Kinetics for Bilirubin Hepatic Uptake and Glucuronidation: Commentary on Dong et al. [PDF]
Clin Pharmacol TherMiners JO, Polasek TM.
europepmc +1 more source
HIV drug resistance, early treatment outcomes and impact of guidelines compliance after protease inhibitor-based second-line failure in a dedicated resistance clinic in western Kenya: a retrospective cohort study. [PDF]
J Int AIDS SocHumphrey JM +11 more
europepmc +1 more source
Insights into Antiviral Candidates against Oropouche Virus: A Molecular Dynamics Study. [PDF]
ACS Phys Chem AuColherinhas G, Cardoso WB.
europepmc +1 more source
Recent Nanotherapeutic Advancements Against HIV-Associated Neurocognitive Disorders (HAND). [PDF]
BiomoleculesTrivedi R, Gothwal A, Layek B, Singh J.
europepmc +1 more source
From virtual screening to animal models: chlorhexidine and indinavir as promising anti-Zika drug candidates. [PDF]
Front Cell Infect MicrobiolZhang HT +7 more
europepmc +1 more source
Contemporary antiretroviral pharmacology in the male genital tract: implications for HIV treatment and prevention. [PDF]
Antimicrob Agents ChemotherNeverette NC +5 more
europepmc +1 more source